rs1776897 — HMGA1

HMGA1 — The Chromatin Architect of Fat Distribution

HMGA1 (High Mobility Group AT-Hook 1) encodes a non-histone chromosomal protein that functions as a transcriptional regulator¹¹ transcriptional regulator
HMGA1 binds to A/T-rich regions of DNA and remodels chromatin structure, enabling other transcription factors to access their target genes. It acts as an architectural transcription factor — rather than directly activating genes, it reshapes the DNA landscape to allow or prevent other regulators from doing their work. The rs1776897 variant sits in an intergenic region near HMGA1 on chromosome 6 and influences where your body preferentially stores fat.

The Mechanism

HMGA1 plays a documented role in insulin signaling and glucose metabolism. Mouse studies²² Mouse studies
HMGA1-deficient mice develop obesity, glucose intolerance, and insulin resistance, demonstrating a causal role for this gene in metabolic regulation have shown that HMGA1 deficiency leads to obesity, glucose intolerance, and insulin resistance. The protein regulates the expression of the insulin receptor itself, and reduced HMGA1 function leads to decreased insulin receptor expression on cell surfaces.

The rs1776897 G allele is associated with altered HMGA1 regulatory activity in adipose tissue, promoting central (abdominal) fat deposition rather than peripheral storage. This variant shows marked sexual dimorphism³³ sexual dimorphism
The effect on WHR is substantially stronger in women than in men, a pattern shared by many fat distribution loci, with stronger effects in women.

The Evidence

The Shungin et al. 2015 meta-analysis⁴⁴ Shungin et al. 2015 meta-analysis
Shungin et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature, 2015 identified the HMGA1 locus among 49 genome-wide significant loci for waist-to-hip ratio adjusted for BMI (WHRadjBMI) across 224,459 individuals. HMGA1 was specifically highlighted as one of the transcriptional regulators at WHRadjBMI loci, and the signal showed stronger effects in women.

A Mendelian randomization study⁵⁵ Mendelian randomization study
Emdin et al. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA, 2017 demonstrated that WHR-raising variants, including the HMGA1 locus, are causally linked to increased risk of type 2 diabetes (OR 1.77 per 1-SD increase in WHR) and coronary heart disease (OR 1.46). This moves the evidence beyond mere association — the fat distribution pattern itself drives metabolic disease.

The largest body fat distribution GWAS to date⁶⁶ largest body fat distribution GWAS to date
Pulit et al. Meta-analysis of genome-wide association studies for body fat distribution in 694,649 individuals of European ancestry. Hum Mol Genet, 2019 confirmed the HMGA1 locus among replicated fat distribution signals across nearly 700,000 individuals.

Practical Actions

The HMGA1 variant's effect on central fat deposition means that waist-to-hip ratio is a more meaningful health metric than BMI or total weight for carriers of the G allele. Central adiposity, even without overall obesity, carries metabolic risk. Monitoring insulin sensitivity markers and focusing on reducing visceral fat specifically are appropriate responses.

Interactions

HMGA1 sits within a broader network of fat distribution loci. The Shungin et al. 2015 pathway analysis implicated adipogenesis, angiogenesis, transcriptional regulation, and insulin resistance as interconnected processes. Carriers of WHR-raising alleles at multiple loci (including TFAP2B rs987237 and VEGFA rs6905288) may have compounded central adiposity risk, though formal gene-gene interaction studies are limited for these specific combinations.